Salmon growth hormone

Scientists have been able to genetically engineer a variety of salmon that grows at twice the rate of Atlantic salmon. The fish is no bigger than the Atlantic salmon, but it reaches that size in half the time. Scientists inserted a Chinook salmon growth hormone gene into a fertilized egg of an Atlantic... 

Boeuf, G., Le Bail, G. and Prunet, P. (1989). Growth hormone and thyroid hormones during Atlantic salmon smolting and after transfer to sea water. Aquaculture 82, 257-268. 

Leatherland, J.F., McKeown, B.A. and John, T.M. (1974). Circadian rhythm of plasma prolactin, growth hormone, glucose and free fatty acid in juvenile kokanee salmon, Oncorhynchus nerka. Comparative Biochemistry and Physiology 47A, 821-828. 

Shrimpton, J.M. and S.D. McCormick. Regulation of gill cytosolic corticosteroid receptors in juvenile Atlantic salmon interaction effects of growth hormone with prolactin and triiodothyronine. Gen. Comp. Endocrinol. 112 262-274, 1998. 

Fukada, H., M. Ban, H. Chiba and A. Hara. Immune complex transfer two-site chemiluminescent immunoassay for serum growth hormone in alevin chum salmon. J. Biolumin. Chemilumin. 13 107-111, 1998. 

IGF 1 will also produce reduction on bodyfat levels in much the same way as conventional growth hormone and for very similar reasons. For this reason, the diet must have a level of essential fatty acids. I suggest supplementing with a daily tablespoon of extra virgin olive oil for the omega three fatty acids plus a daily portion of fresh water fish like salmon, trout, or even sardine. 

A. Mero, M. Schiavon, FM. Veronese, G. Pasut, A new method to increase selectivity of transglutaminase mediated PEGylation of salmon calcitonin and human growth hormone. /. Control. Release, 154 (1) 27-34, 2011. 

N I7.49%To 22.35%. Synthetic analog of eel calcitonin amino acid sequence also similar to that of salmon calcitonin. Polypeptide hormone effective in the reduction of plasma calcium. More stable than natural calcitonins because of the absence of disulfide bridges. Prepn S. Saka-kibara et at, Ger. pat. 2,616,399 eidem, LI.S. pat. 4,086,221 (1976, 1978 both to Toyo Jozo) T. Morikawa et ah, Experientia 32, 1104 (1976). In vitro growth inhibition of human breast cancer cells Y. Iwasaki et at, Biochem. Blophys. Res. Common. 110, 235 (1983). Clinical pharmacology T, Ishi-oka, Pharmatherapeutica 1, 625 (1977). Clinical study in Paget s disease A. Caniggia er ah, Minerva Med. 74, 993 (1983) in osteoporosis Italian Osteoporosis Network, Curr, Ther. Res. 45, 502 (1989). 

---